Cellular ion concentrations were thought to be fairly constant, but scientists have now found heart cells actually alter their internal sodium and potassium levels across the day and night. This anticipates the daily demands of our lives, allowing the heart to better accommodate and sustain increased heart rate when we’re active.
It is already known there are daily clocks in heart cells, and other tissues; normally synchronized by hormonal signals that align our internal daily rhythms with the day/ night cycle. Daily rhythms of heart function have been known about for years and thought to be due to greater stimulation by the nervous system during the day.
This new study, supported by the Medical Research Council and AstraZeneca Blue Sky Initiative, shows circadian rhythms within each heart cell can also affect heart rate.
The team say understanding how these changes in ion levels alter heart function over the day may help to explain why shift workers are more vulnerable to heart problems – because ion rhythms driven by clocks in the heart get ‘out of sync’ with their stimulation from clocks in the brain. This new understanding could lead to better treatments and preventative measures for combatting heart conditions.
The study, published in the journal Nature Communications, found these daily rhythms in sodium and potassium occur to allow changes in cellular proteins, with ions literally being pumped out to ‘make room’ for daily increases in protein level.
The study’s lead author, Alessandra Stangherlin, was amazed to find sodium/potassium levels changing by as much as 30% in isolated cells and heart tissue. This imparts a striking two-fold daily variation to the electrical activity of isolated heart cells. In mice, this appears to be just as relevant to understanding daily changes in heart rate as nervous control.
Dr John O’Neill, from the MRC Laboratory of Molecular Biology, who led the study, said: “The ways in which heart function changes around the clock turn out to be more complex than previously thought. The ion gradients that contribute to heart rate vary over the daily cycle. This likely helps the heart cope with increased demands during the day, when changes in activity and cardiac output are much greater than at night, when we normally sleep. It opens up the exciting possibility of more effective treatments for cardiovascular conditions, for example by delivering drugs at the right time of day.”
While this study was conducted using cells and mice in the lab, its findings are supported by a recent linked study by collaborators, led by Professor David Bechtold at the University of Manchester. Their study demonstrated that circadian rhythms in heart rate and electrical activity are clearly evident in both mice and humans, and that abrupt changes in behavioral routine or sleep patterns can disturb these normal heart rhythms.
Taken together, these studies suggest that lifestyles which oppose our natural internal clock (such as shift work), may cause internal circadian rhythms within heart cells to become de-coupled from our behaviours so that heart clocks no longer anticipate the fluctuations in demand that, for most individuals, will be higher in the daytime.
They propose this contributes to the increased risk of adverse events, such as arrhythmias and sudden cardiac death, when circadian rhythms are disrupted.
Dr John O’Neill said: “Many life-threatening problems with the heart happen at specific times of day, and more often in shift workers. We think that when the circadian clocks in the heart become desynchronised from those in the brain, as during shift work, our cardiovascular system may be less able to deal with the daily stresses of working life. This likely renders the heart more vulnerable to dysfunction.”
Peter Newham, VP, Clinical Pharmacology and Safety Sciences, R&D, AstraZeneca, commented: “This collaboration is a wonderful example of why AstraZeneca is located in Cambridge, one of the most exciting bioscience hotspots in the world. Having the MRC Laboratory for Molecular Biology and John and Alessandro on our doorstep really helped fuel this collaboration, bringing together our different perspectives and experience to advance science.”
Dr Megan Dowie, head of molecular and cellular medicine at the Medical Research Council, which funded the study, said: “This really interesting research supported through the Blue Sky Initiative shows the incredible potential for innovative academic-industry relationships to push the frontiers of discovery science. It addresses fundamental, unanswered questions about how the body works and points to exciting new possibilities for therapeutic innovations.”
Source: Medindia
For all the latest Health News Click Here
For the latest news and updates, follow us on Google News.
Denial of responsibility! NewsBit.us is an automatic aggregator around the global media. All the content are available free on Internet. We have just arranged it in one platform for educational purpose only. In each content, the hyperlink to the primary source is specified. All trademarks belong to their rightful owners, all materials to their authors. If you are the owner of the content and do not want us to publish your materials on our website, please contact us by email – [email protected]. The content will be deleted within 24 hours.
